Immunovative Therapies

Immunovative Therapies, Ltd. is an Israeli biotechnology company founded in 2004 by Dr. Michael Har-Noy Ph.D. Immunovative Therapies, Ltd. develops unique drugs that fight cancer using immune system manipulation. These revolutionary new compounds produce the same tumor-killing effect of a successful bone marrow transplant without the potentially lethal complication of graft-versus-host disease. Preliminary studies have shown that Immunovative Therapies, Ltd.’s unique drugs have powerful activity against a wide variety of malignancies and may completely revolutionize the field of oncology.